A Phase 4 interventional study of corrective osteotomy distal radius in Dorsal Malunion of the Distal Radius, sponsored by Oslo University Hospital. Completed. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-06.
Sponsored by Oslo University Hospital · Phase 4, Interventional, and Treatment
CaP Cement is Equivalent to Iliac Bone Graft in Filling of Large Metaphyseal Defects
Background: A bone graft from the iliac crest has long been the gold standard for filling voids in opening wedge osteotomies. CaP bone cement has been considered the possible alternative to bone graft.
Methods: 20 adult patients with distal radius malunions and dorsal deformities were randomised intra-operatively to bone graft (10) or CaP bone cement (10). Dorsal titanium locking plates were used and the wrist was stabilised in a cast for 8 weeks. Follow-ups for 24 months included VAS on wrist and iliac crest, grip strength, ROM bilaterally, Quick-DASH and Gartland \& Werley's functional scoring system. X-rays and CT scans were taken at 8 wks, 3-6-12-24 mths.
Oslo University Hospital is the lead sponsor of 810 studies on the registry; 148 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Bone graft from iliac crest as gapfiller
Procedure: corrective osteotomy distal radius
CaP bone cement as gapfiller
Procedure: corrective osteotomy distal radius
Opening wedge corrective osteotomy on dorsal malunions of the distal radius. Distraction and correction of deformity.
volar angulation distal radius, x-ray
Time frame: 24 months
No study locations are listed for this record.
Plan to share: Yes
No publications or documents are linked to this record.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oslo University Hospital